Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P09429
UPID:
HMGB1_HUMAN
Alternative names:
High mobility group protein 1
Alternative UPACC:
P09429; A5D8W9; Q14321; Q5T7C3; Q6IBE1
Background:
High mobility group protein B1 (HMGB1) serves as a pivotal redox-sensitive protein with diverse roles across cellular compartments. It functions as a DNA chaperone in the nucleus, facilitating replication, transcription, and DNA repair, thereby maintaining genome stability. HMGB1 acts as a sensor for immunogenic nucleic acids in the cytoplasm, triggering autophagy and immune responses. Additionally, it plays a role in inflammation, tissue repair, and immune system modulation by acting as a danger-associated molecular pattern (DAMP) molecule.
Therapeutic significance:
Understanding the role of High mobility group protein B1 could open doors to potential therapeutic strategies.